A raft of pilot schemes designed to bridge gaps between health and social care services started this week. The nationwide …
US prescription sales growth was just 1.3% in 2008, well down on the typical 5%-plus in recent years, according to …
The standard of care for patients with inflammatory bowel disease in the UK remains "unacceptably" variable. The second national audit …
Analysts Datamonitor believe that telehealth has reached the tipping point in terms of awareness, with IBM following Intel's entrance into …
Takeda Pharmaceutical Company is shifting its global development HQ from Japan to the US. The move will see that function …
Bayer Schering Pharma has joined the ranks of firms switching to restrictive distribution arrangements in the UK. The pharma company, …
Everyone in England aged 40-74 is to get a health check on the NHS in an attempt to identify major …
Genentech's decision to succumb to Roche's $48.8 billion merger bid has signalled a revamp of manufacturing, R&D and other divisions …
Jade Goody has left a legacy of hugely increased awareness of cervical cancer in the UK, following her death from …
New guidance to patients to raise public awareness of fake medicine and its dangers has been launched by the RPSGB …
GSW Worldwide, one of the biggest global healthcare advertising agencies has announced the launch of a new pan-European offering. GSW …
Merck & Co has increased its investment in a new biologic and vaccines facility in Carlow, Ireland, to 220 million …
The 2009 Health Bill is the latest major piece of legislation aimed at transforming the NHS, and introduces a range …
There was a sharp slowdown in pharmaceutical outsourcing in the last six months which "really caught a lot of people …
GlaxoSmithKline is to make its clinical trials more transparent through a series of moves it believes will facilitate clinical research. …
NICE has issued its final guidance on Pfizer's Sutent, recommending the kidney cancer drug as a first-line treatment. The drug …
GlaxoSmithKline may be considering a bid to buy Allergan, the company behind 'cosmaceutical' products such as Botox. Analysts have seized …
Biopharmaceutical manufacturing is likely to undergo a dramatic change over the next 20 years, with the today's facilities facing dramatic …